You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

627 Results
Regimen
Cancer Type:
Gastrointestinal, 
Rectal
Intent: Neoadjuvant
Updated
Oct 2025
Regimen
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
New
Oct 2025
Drug
Other Name(s): Ibrance™
Updated
Oct 2025

Pages